NPC's John O'Brien to Speak at BIO 2025
NPC's John O'Brien will moderate a discussion on accelerated approval and the value of earlier access to patients.
Join NPC President and CEO John M. O’Brien, PharmD, MPH at the 2025 BIO International Convention, held this year in Boston, MA.
June 19, 2025 | 9:00 AM - 10:00 AM
Breakout Session: Accelerated Approval and Patient Need: The Value of Earlier Access
The Accelerated Approval Program has been the focus of many recent conversations questioning the impact and value of the pathway for patients. Drugs approved via this pathway have become the latest victims of an insurance system with a financial incentive to say no to new treatments. How do we know if the Accelerated Approval Program is working as intended? How should patient-centered research estimate the risks and benefits of the pathway? What ought industry, policymakers, and payers know about patients’ views as we move forward? What research should be conducted next? This panel will discuss recent research exploring the impact of the Accelerated Approval Program and hear the patient perspective about the value and hope it is providing patients.
Moderator:
- John M. O'Brien, PharmD, MPH, National Pharmaceutical Council
Speakers:
- Jeff Allen, PhD, Friends of Cancer Research
- Paul Howard, PhD, Amicus Therapeutics
- Annie Kennedy, BS, EveryLife Foundation for Rare Diseases
- Silas Martin, Johnson & Johnson
- Sue Peschin, MHS, Alliance for Aging Research
Learn More About the Conference
